Germany’s Merck KGaA Predicts Earnings Gain In 2021

0 68

Germany’s Merck KGaA predicted further earnings gains in 2021 as an effort by the pharma industry to ready treatments and vaccines against the coronavirus bolsters demand for its supplies for biotech labs.

Merck, which also makes pharmaceuticals and specialty chemicals, said on Thursday it expects earnings before interest, taxes, depreciation and amortisation (EBITDA) adjusted for one offs, to grow in the high single-digit to low teens percentage range.

Adjusted EBITDA in 2020 rose 18.6% to 5.2 billion euros ($6.27 billion), it added.

Related Posts

Media Portrayal Of Nigeria Led Twitter To Choose Ghana For…

Inflationary Pressures To Feed Expectations For Further…


Leave A Reply

Your email address will not be published.

%d bloggers like this: